Charles Zhu
Stock Analyst at LifeSci Capital
(3.18)
# 1,165
Out of 4,761 analysts
24
Total ratings
47.62%
Success rate
15.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | $1.29 | - | 1 | Dec 13, 2024 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $8 | $2.36 | +238.98% | 3 | Nov 7, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | $12 | $2.76 | +334.78% | 4 | Nov 7, 2023 | |
| MRUS Merus | Maintains: Buy | $46 → $48 | $47.37 | +1.33% | 6 | Aug 8, 2023 | |
| NUVL Nuvalent | Initiates: Buy | $56 | $79.49 | -29.55% | 1 | Jul 24, 2023 | |
| TARA Protara Therapeutics | Assumes: Buy | $22 | $3.72 | +491.40% | 1 | Jul 10, 2023 | |
| COGT Cogent Biosciences | Reiterates: Buy | $26 | $8.00 | +225.00% | 3 | Jun 13, 2023 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $32 | $21.85 | +46.45% | 3 | Mar 8, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $14 | $14.39 | -2.71% | 2 | May 5, 2022 |
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.29
Upside: -
Tango Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $18 → $8
Current: $2.36
Upside: +238.98%
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $2.76
Upside: +334.78%
Merus
Aug 8, 2023
Maintains: Buy
Price Target: $46 → $48
Current: $47.37
Upside: +1.33%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $79.49
Upside: -29.55%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $3.72
Upside: +491.40%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $8.00
Upside: +225.00%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $21.85
Upside: +46.45%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $14.39
Upside: -2.71%